Higher consumption of olive oil in the PREDIMED randomized controlled trial was associated with significantly lower cardiovascular mortality.
Most of the olive oil consumed by the intervention group was as EVOO.
The risk of dying of CVD was cut by almost 50% in the participants consuming the most olive oil.
There was a clear dose-effect relationship: Every extra 10g of olive oil consumed per day (roughly one tablespoon) cut the risk of dying from CVD during the 5 year trial by 7%.
Note that this was a primary prevention trial. None of the participants had been diagnosed with CVD prior to the start of the trial. Every extra 10g of olive oil per day cut the risk of developing CVD during the trial by 10%.
PREDIMED also showed that olive oil reduced all-cause mortality, but the results did not reach the typical cutoff used for statistical significance in medical studies. See comments for more on all-cause mortality in this study.
Quoted:
“Higher baseline total olive oil consumption was associated with 48% (HR: 0.52; 95% CI: 0.29 to 0.93) reduced risk of cardiovascular mortality. For each 10 g/d increase in extra-virgin olive oil consumption, cardiovascular disease and mortality risk decreased by 10% and 7%, respectively. No significant associations were found for cancer and all-cause mortality. The associations between cardiovascular events and extra virgin olive oil intake were significant in the Mediterranean diet intervention groups and not in the control group.”
“Conclusion - Olive oil consumption, specifically the extra-virgin variety, is associated with reduced risks of cardiovascular disease and mortality in individuals at high cardiovascular risk.”
#evooHD #oliveoilHD #mediterraneanHD #predimedHD #mediterraneanrctHD

